Abstract Background and Aim: Decisions on public health issues are dependent on reliable
epidemiological data. A comprehensive review of the literature was used to gather country …

The epidemic of hepatitis C virus (HCV) infection in Europe is continuously evolving and
epidemiological parameters (prevalence, incidence, disease transmission patterns and …

Hepatitis C virus (HCV) is one of the leading causes of chronic liver disease, cirrhosis, and
hepatocellular carcinoma, resulting in major global public health concerns. The HCV …

Infection with hepatitis C virus (HCV) genotypes 4–6 (with the previously named genotypes
7–9 included as subtypes of genotype 6) is distributed and studied less widely than …

Hepatitis C (HCV) is the disease that has affected around 200 million people globally. HCV
is a life threatening human pathogen, not only because of its high prevalence and worldwide …

BACKGROUND & AIMS: The dynamics of hepatitis C virus (HCV) infection, as well as
screening practices and access to therapy, vary among European countries. It is important to …

The epidemiological picture of hepatitis C virus (HCV) infection in the general population is
largely unknown, even in developed countries. The aim of this study was to estimate the …

It is well established that hepatitis C develops into cirrhosis of the liver and hepatocellular
carcinoma (HCC) both of which are fatal diseases. The World Health Organization estimates …

To describe the spread of hepatitis C virus (HCV) among HCV/human immunodeficiency
virus (HIV)–coinfected injection drug users (IDUs), the molecular epidemiology of HCV was …

Background The global burden of hepatitis C (HCV) infection is mostly found in Africa, the
Middle East and Asia, where HCV genotypes 4, 5 and 6 are common. The literature on these …